Saltar al contenido
Salud cardiovascularEstudio de cohorte4 min read

Higher midlife estimated fitness linked to lower hypertension, diabetes and CVD risk

Colectivo editorial MoveVitals · Study published · Reading updated

Original paper:Association of Estimated Cardiorespiratory Fitness in Midlife With Cardiometabolic Outcomes and Mortality. · JAMA network open · 2021 · Artículo original ↗

Idea principal

In 2962 Framingham Study participants followed for a mean of 15 years, high midlife estimated fitness was linked to lower risk of hypertension (HR 0.63), diabetes (HR 0.38) and cardiovascular disease (HR 0.71). But estimated fitness is a formula score using age, BMI, waist, activity, resting heart rate and smoking, so it cannot isolate fitness itself.

Study design

Estudio de cohorte

Reading basis

Published abstract

Reading focus

Association & confounding

Esta explicación editorial está disponible en inglés, chino simplificado y chino tradicional. Esta interfaz muestra la lectura en inglés.

Pregunta de investigación

Fitness in midlife may shape later vascular health, but how estimated cardiorespiratory fitness (eCRF) relates to early artery disease, arterial stiffness, new cardiometabolic disease and death was not well understood. The authors examined whether midlife eCRF, its average, and its trajectory between examination cycles 2 and 7 (1979 to 2001) were associated with these outcomes.

Población y método

Cohort study of 2962 participants in the Framingham Study Second Generation (mean age 61.5, SD 9.2 years; 1562, or 52.7%, women). eCRF came from sex-specific algorithms using age, body mass index, waist circumference, physical activity, resting heart rate and smoking. It was grouped as tertiles at examination cycle 7 (1998 to 2001), tertiles of the average across cycles 2 to 7 (1979 to 2001), and trajectories across cycles 2 to 7, with the lowest group as reference. Outcomes were carotid intima-media thickness (CIMT), coronary artery calcium (CAC) score, arterial stiffness (carotid-femoral pulse wave velocity, CFPWV), and new hypertension, diabetes, chronic kidney disease (CKD), cardiovascular disease (CVD) and death after cycle 7 (mean follow-up 15 years). Data were analysed from January 2020 to June 2020.

Resultados

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    After cycle 7, 728 of 1506 people at risk developed hypertension, 214 of 2268 diabetes, 439 of 2343 CKD and 500 of 2608 CVD, and 770 of 2962 died.
  2. 2
    High single-examination eCRF versus low was linked to lower arterial stiffness (CFPWV, β -11.13, SE 1.33 ms/m) and thinner carotid walls (CIMT, β -0.12, SE 0.05 mm), and to lower risk of hypertension (HR 0.63, 95% CI 0.46-0.85), diabetes (HR 0.38, 95% CI 0.23-0.62) and CVD (HR 0.71, 95% CI 0.53-0.95). It was not associated with CKD or mortality.
  3. 3
    A high eCRF trajectory and a high average eCRF (each versus low) were linked to lower CFPWV (β -11.85 and -10.36), lower CIMT (β -0.19 and -0.15 mm) and lower CAC scores (β -0.67 and -0.63 AU).
  4. 4
    For the high trajectory and the high average respectively: hypertension HR 0.54 (95% CI 0.34-0.87) and 0.48 (0.34-0.68); diabetes 0.27 (0.15-0.48) and 0.31 (0.18-0.54); CKD 0.63 (0.40-0.97) and 0.64 (0.44-0.94); CVD 0.46 (0.31-0.68) and 0.43 (0.30-0.60).
  5. 5
    A high eCRF trajectory was linked to lower mortality (HR 0.69, 95% CI 0.50-0.95), whereas a single high examination was not.

Límites e incertidumbre

  1. 1
    eCRF is calculated, not measured. It includes BMI, waist, activity, resting heart rate and smoking, which relate to these outcomes on their own, so the results may reflect those components rather than fitness.
  2. 2
    This is an observational cohort, and the abstract does not list which factors the outcome models adjusted for, so other lifestyle or health differences may remain.
  3. 3
    Several outcomes and exposure definitions were tested, and results differ between them: CKD and mortality were not associated with a single examination, while CKD was associated with trajectory and average and mortality with trajectory, so isolated findings deserve caution.
  4. 4
    It is one sample from the Framingham Second Generation cohort examined from 1979 to 2001, and the abstract does not describe ethnic makeup; results may not carry over to people measured with a watch today. This reading is based on the abstract only.

Relevancia práctica

In this cohort, people whose estimated fitness was higher in midlife, and especially those who stayed high over the years, had lower arterial stiffness and carotid wall thickness and fewer new cases of hypertension, diabetes and cardiovascular disease. It shows association, not that raising the score would change outcomes. Questions about your own risk belong with your clinician.

Tus datos

Several inputs of eCRF are things people already log: resting heart rate from a watch, steps or activity, weight and waist, and smoking status. A watch VO2max estimate uses different methods, so do not plug it into these results; compare it with your own earlier values from the same device. Trends over months in resting heart rate and VO2max estimate say more than any single reading.

Cómo interpretar la evidencia

Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.

Resumen estructurado de los autores English

El resumen original en inglés se reproduce con atribución bajo la licencia indicada. Es una fuente, no una interpretación de MoveVitals. El análisis preparado figura arriba; verifica los resultados importantes en la fuente.

Importance

The associations of estimated cardiorespiratory fitness (eCRF) during midlife with subclinical atherosclerosis, arterial stiffness, incident cardiometabolic disease, and mortality are not well understood.

Objective

To examine associations of midlife eCRF with subclinical atherosclerosis, arterial stiffness, incident cardiometabolic disease, and mortality.

Design, setting, and participants

This cohort study included 2962 participants in the Framingham Study Second Generation (conducted between 1979 and 2001). Data were analyzed from January 2020 to June 2020.

Exposures

eCRF was calculated using sex-specific algorithms (including age, body mass index, waist circumference, physical activity, resting heart rate, and smoking) and was categorized as: (1) tertiles of standardized eCRF at examination cycle 7 (1998 to 2001); (2) tertiles of standardized average eCRF between examination cycles 2 and 7 (1979 to 2001); and (3) eCRF trajectories between examination cycles 2 and 7, with the lowest tertile or trajectory (ie, low eCRF) as referent group.

Main outcomes and measures

Subclinical atherosclerosis (carotid intima-media thickness [CIMT], coronary artery calcium [CAC] score); arterial stiffness (carotid-femoral pulse wave velocity [-1000/CFPWV]); incident hypertension, diabetes, chronic kidney disease (CKD), cardiovascular disease (CVD), and mortality after examination cycle 7.

Results

A total of 2962 participants were included in this cohort study (mean [SD] age, 61.5 [9.2] years; 1562 [52.7%] women). The number of events or participants at risk after examination cycle 7 (at a mean follow-up of 15 years) was 728 of 1506 for hypertension, 214 of 2268 for diabetes, 439 of 2343 for CKD, 500 of 2608 for CVD, and 770 of 2962 for mortality. Compared with the low eCRF reference value, high single examination eCRF was associated with lower CFPWV (β [SE], -11.13 [1.33] ms/m) and CIMT (β [SE], -0.12 [0.05] mm), and lower risk of hypertension (hazard ratio [HR], 0.63; 95% CI, 0.46-0.85), diabetes (HR, 0.38; 95% CI, 0.23-0.62), and CVD (HR, 0.71; 95% CI, 0.53-0.95), although it was not associated with CKD or mortality. Similarly, compared with the low eCRF reference, high eCRF trajectories and mean eCRF were associated with lower CFPWV (β [SE], -11.85 [1.89] ms/m and -10.36 [1.54] ms/m), CIMT (β [SE], -0.19 [0.06] mm and -0.15 [0.05] mm), CAC scores (β [SE], -0.67 [0.25] AU and -0.63 [0.20] AU), and lower risk of hypertension (HR, 0.54; 95% CI, 0.34-0.87 and HR, 0.48; 95% CI, 0.34-0.68), diabetes (HR, 0.27; 95% CI, 0.15-0.48 and HR, 0.31; 95% CI, 0.18-0.54), CKD (HR, 0.63; 95% CI, 0.40-0.97 and HR, 0.64; 95% CI, 0.44-0.94), and CVD (HR, 0.46; 95% CI, 0.31-0.68 and HR, 0.43; 95% CI, 0.30-0.60). Compared with the reference value, a high eCRF trajectory was associated with lower risk of mortality (HR, 0.69; 95% CI, 0.50-0.95).

Conclusions and relevance

In this cohort study, higher midlife eCRF was associated with lower burdens of subclinical atherosclerosis and vascular stiffness, and with a lower risk of hypertension, diabetes, chronic kidney disease, cardiovascular disease, and mortality. These findings suggest that midlife eCRF may serve as a prognostic marker for subclinical atherosclerosis, arterial stiffness, cardiometabolic health, and mortality in later life.

Fuentes y atribución

Association of Estimated Cardiorespiratory Fitness in Midlife With Cardiometabolic Outcomes and Mortality.

Lee J, Song RJ, Musa Yola I, Shrout TA, Mitchell GF, Vasan RS, Xanthakis V.

JAMA network open · 2021-10-01

DOI: 10.1001/jamanetworkopen.2021.31284 ↗PubMed · 34714339 ↗Europe PMC · Licencia registrada: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

Interpretación editorial de MoveVitals · contenido educativo · sin revisión clínica individual registrada

Fuentes verificadas 2026-11-01

Guías prácticas

Leer en contexto

·Metaanálisis observacional

Disrupted daily rest-activity rhythm is linked to higher mortality in 109,365 people

Across seven observational studies with 109,365 participants, a weaker day-night activity contrast (lower relative amplitude) was associated with higher cardiovascular mortality (hazard ratio [HR] 1.50, 95% CI 1.13 to 1.98) and all-cause mortality (HR 1.46, 95% CI 1.27 to 1.68). The evidence base is small and observational, so it cannot show that improving the rhythm lowers risk, and illness may itself disturb the rhythm.

Journal of the American Heart Association

Explicaciones detalladasLeer estudio →
·Metaanálisis de ensayos

Five exercise types lowered resting blood pressure, isometric training the most

Pooling 270 randomised trials with 15,827 participants, aerobic, resistance, combined, interval and isometric training all lowered resting blood pressure compared with non-intervention controls (P<0.001 for each), with the largest fall for isometric training: 8.24 mm Hg systolic and 4.00 mm Hg diastolic. The ranking between modes is partly indirect and the trials differ, so it is not a personal prescription.

British Journal of Sports Medicine

Explicaciones detalladasLeer estudio →
·Ensayo aleatorizado

A salt substitute lowered stroke, major cardiovascular events and death in rural China

In 20,995 people in 600 rural Chinese villages who had a history of stroke or were 60 or older with high blood pressure, a salt substitute (75% sodium chloride, 25% potassium chloride) lowered the stroke rate versus regular salt over a mean 4.74 years: 29.14 versus 33.65 events per 1000 person-years (rate ratio 0.86, 95% CI 0.77 to 0.96; P = 0.006). Death was also lower (rate ratio 0.88) and serious hyperkalemia events were not significantly higher, but the trial was open-label and set in rural China.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
·Estudio/revisión de validación

Apple Watch irregular-pulse alerts were rare; 34% of those tested had atrial fibrillation

Among 419,297 Apple Watch users with no known atrial fibrillation (AF), 0.52% received an irregular-pulse alert, and 34% of the 450 who returned a usable ECG patch had AF (97.5% CI 29 to 39). Alerts that coincided with patch recording matched AF with a positive predictive value of 0.84 (95% CI 0.76 to 0.92), but only 20.8% of alerted people returned a patch and nobody without an alert was monitored, so a quiet watch does not rule AF out.

The New England Journal of Medicine

Explicaciones detalladasLeer estudio →
Salud cardiovascular →